David Natan insider trades

Open-market stock purchases and sales by David Natan, Director at Aterian, Inc, from SEC Form 4 filings since Feb 18, 2010.

Recent trades

DateStockTradeValue
Sep 25, 2026ATER Aterian, IncBought (not open market)—
Aug 7, 2026SBFM Sunshine Biopharma IncBought (not open market)—
Jul 31, 2026QUCY Quantum Cyber NVBought (not open market)—
Jul 22, 2026QUCY Quantum Cyber NVBought (not open market)—
May 8, 2026MYNZ Quantum Cyber NVBought (not open market)—
May 5, 2026FIEE FiEE, IncBought (not open market)—
Apr 14, 2026SBFM Sunshine Biopharma IncBought (not open market)—
Mar 30, 2026SOWG Sow Good IncBought (not open market)$129K
Jan 7, 2026INDP Indaptus Therapeutics, IncBought (not open market)—

Companies traded

  • ATER Aterian, Inc: other filings, last Sep 25, 2026
  • SBFM Sunshine Biopharma Inc: other filings, last Aug 7, 2026
  • QUCY Quantum Cyber NV: other filings, last Jul 31, 2026
  • MYNZ Quantum Cyber NV: other filings, last May 8, 2026
  • FIEE FiEE, Inc: other filings, last May 5, 2026
  • SOWG Sow Good Inc: other filings, last Mar 30, 2026
  • INDP Indaptus Therapeutics, Inc: other filings, last Jan 7, 2026
  • CYCC Cyclacel Pharmaceuticals, Inc: other filings, last Feb 26, 2025
  • MINM Minim, Inc: other filings, last Sep 26, 2024
  • OPGN Opgen Inc: other filings, last Apr 11, 2024
  • TTNP Titan Pharmaceuticals Inc: other filings, last Oct 25, 2023
  • GDMK Global Diversified Marketing Group Inc: other filings, last Apr 25, 2022

Get free alerts when David Natan files a new trade →